US Obesity Market and Competitive Landscape Highlights - 2016

  • ID: 3680024
  • Drug Pipelines
  • Region: United States
  • Fore Pharma
1 of 3
The latest research US Obesity Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Obesity pipeline products, Obesity epidemiology, Obesity market valuations and forecast, Obesity products sales and competitive landscape in the US.

The research is classified into nine sections – Obesity overview including etiology, pathophysiology, and diagnosis, Obesity treatment options, Obesity pipeline products, Obesity market analysis comprising of Obesity epidemiology, key products marketed for Obesity, market valuations and forecast, products sales and market shares.

Research Scope:
- Obesity Pipeline: Find out the products in clinical trials for the treatment of Obesity by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
- Obesity Epidemiology: Find out the number of patients diagnosed (prevalence) with Obesity in the US
- Obesity Products: Identify key products marketed and prescribed for Obesity in the US, including trade name, molecule name, and company
- Obesity Product Sales: Find out the sales revenues of Obesity products, both branded and generics, in the US
- Obesity Market Valuations: Find out the market size for Obesity products in 2015 in the US. Find out how the market advanced from 2010 and forecast to 2020
- Obesity Products Market Share: Find out the market shares for key Obesity products in the US

Benefits of this Research:
The research helps executives to
- Support monitoring and reporting national Obesity market analysis and sales trends
- Track competitor drugs sales and market share in the US Obesity market
- Track competitive developments in Obesity market and present key issues and learnings
- Synthesize insights for Obesity market and products to drive business performance
- Answer key business questions about the Obesity market
- Evaluate commercial market opportunity assessment, positioning, and segmentation for Obesity products
- Supports decision making in R&D to long term marketing strategies

This report will take 1-2 business days to deliver.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1) Disease Overview
a) Etiology
b) Pathophysiology
c) Diagnosis
2) Obesity Treatments
3) Obesity Pipeline
4) US Obesity Epidemiology
5) Marketed Drugs for Obesity in US
6) US Obesity Market Size
7) US Obesity Products Sales
8) US Obesity Market Competitive Landscape
9) US Obesity Market Forecast
10) Methodology
11) Contact us

1. Obesity Epidemiology, US, 2010 - 2020
2. Obesity Market Size ($), US, 2010 – 2015
3. Obesity Products Market Share (%), US, 2015
4. Obesity Market Forecast ($), US, 2015 – 2020

1. Obesity Phase 3 Clinical Trials, 2016
2. Obesity Phase 2 Clinical Trials, 2016
3. Obesity Phase 1 Clinical Trials, 2016
4. Obesity Epidemiology, US, 2010 - 2020
5. Marketed Drugs for Obesity, US, 2016
6. Obesity Market Size ($), US, 2010 – 2015
7. Obesity Product Sales ($), US, 2010 – 2015
8. Obesity Market Forecast ($), US, 2015 – 2020
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll